nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE6A—mammalian vulva—uterine cancer	0.0102	0.0337	CbGeAlD
Dipyridamole—PRUNE—Podofilox—Etoposide—uterine cancer	0.00944	1	CbGdCrCtD
Dipyridamole—PRUNE—uterine cervix—uterine cancer	0.00739	0.0244	CbGeAlD
Dipyridamole—PDE6D—uterine cervix—uterine cancer	0.00714	0.0236	CbGeAlD
Dipyridamole—PDE6D—decidua—uterine cancer	0.0068	0.0224	CbGeAlD
Dipyridamole—PDE5A—artery—uterine cancer	0.0066	0.0218	CbGeAlD
Dipyridamole—PDE11A—epithelium—uterine cancer	0.00658	0.0217	CbGeAlD
Dipyridamole—PRUNE—uterus—uterine cancer	0.00616	0.0203	CbGeAlD
Dipyridamole—PDE6D—uterus—uterine cancer	0.00595	0.0196	CbGeAlD
Dipyridamole—PDE2A—myometrium—uterine cancer	0.00545	0.018	CbGeAlD
Dipyridamole—PDE7A—renal system—uterine cancer	0.00544	0.018	CbGeAlD
Dipyridamole—PDE6D—female reproductive system—uterine cancer	0.00535	0.0176	CbGeAlD
Dipyridamole—PRUNE—female gonad—uterine cancer	0.00504	0.0166	CbGeAlD
Dipyridamole—PDE6D—female gonad—uterine cancer	0.00486	0.0161	CbGeAlD
Dipyridamole—PDE6D—vagina—uterine cancer	0.00484	0.016	CbGeAlD
Dipyridamole—PDE6B—vagina—uterine cancer	0.00476	0.0157	CbGeAlD
Dipyridamole—PDE8A—myometrium—uterine cancer	0.00468	0.0154	CbGeAlD
Dipyridamole—PDE7A—female reproductive system—uterine cancer	0.00436	0.0144	CbGeAlD
Dipyridamole—PDE2A—uterine cervix—uterine cancer	0.00424	0.014	CbGeAlD
Dipyridamole—PDE8B—uterine cervix—uterine cancer	0.00405	0.0134	CbGeAlD
Dipyridamole—PDE2A—decidua—uterine cancer	0.00404	0.0133	CbGeAlD
Dipyridamole—PDE10A—decidua—uterine cancer	0.00404	0.0133	CbGeAlD
Dipyridamole—ADA—myometrium—uterine cancer	0.00385	0.0127	CbGeAlD
Dipyridamole—PDE2A—mammalian vulva—uterine cancer	0.00371	0.0123	CbGeAlD
Dipyridamole—PDE8A—uterine cervix—uterine cancer	0.00364	0.012	CbGeAlD
Dipyridamole—PDE1C—lymph node—uterine cancer	0.00359	0.0118	CbGeAlD
Dipyridamole—PDE8A—smooth muscle tissue—uterine cancer	0.00354	0.0117	CbGeAlD
Dipyridamole—PDE2A—uterus—uterine cancer	0.00354	0.0117	CbGeAlD
Dipyridamole—PDE1A—uterine cervix—uterine cancer	0.00352	0.0116	CbGeAlD
Dipyridamole—PDE8A—decidua—uterine cancer	0.00347	0.0115	CbGeAlD
Dipyridamole—PDE1A—smooth muscle tissue—uterine cancer	0.00342	0.0113	CbGeAlD
Dipyridamole—PDE8B—uterus—uterine cancer	0.00337	0.0111	CbGeAlD
Dipyridamole—PDE1A—renal system—uterine cancer	0.0033	0.0109	CbGeAlD
Dipyridamole—PDE8A—endometrium—uterine cancer	0.00329	0.0109	CbGeAlD
Dipyridamole—PRUNE—lymph node—uterine cancer	0.00324	0.0107	CbGeAlD
Dipyridamole—PDE8A—mammalian vulva—uterine cancer	0.00319	0.0105	CbGeAlD
Dipyridamole—PDE2A—female reproductive system—uterine cancer	0.00318	0.0105	CbGeAlD
Dipyridamole—PDE1B—female reproductive system—uterine cancer	0.00315	0.0104	CbGeAlD
Dipyridamole—PDE6D—lymph node—uterine cancer	0.00313	0.0103	CbGeAlD
Dipyridamole—PDE8A—uterus—uterine cancer	0.00303	0.01	CbGeAlD
Dipyridamole—PDE8B—female reproductive system—uterine cancer	0.00303	0.01	CbGeAlD
Dipyridamole—PDE1A—uterus—uterine cancer	0.00294	0.00969	CbGeAlD
Dipyridamole—PDE10A—female gonad—uterine cancer	0.00289	0.00955	CbGeAlD
Dipyridamole—PDE2A—vagina—uterine cancer	0.00288	0.00949	CbGeAlD
Dipyridamole—ADA—decidua—uterine cancer	0.00285	0.00942	CbGeAlD
Dipyridamole—ADA—renal system—uterine cancer	0.0028	0.00925	CbGeAlD
Dipyridamole—PDE4A—decidua—uterine cancer	0.00278	0.00918	CbGeAlD
Dipyridamole—PDE6G—lymph node—uterine cancer	0.00275	0.00909	CbGeAlD
Dipyridamole—PDE8B—vagina—uterine cancer	0.00274	0.00905	CbGeAlD
Dipyridamole—SLC29A1—myometrium—uterine cancer	0.00268	0.00884	CbGeAlD
Dipyridamole—PDE1A—female reproductive system—uterine cancer	0.00264	0.00872	CbGeAlD
Dipyridamole—ADA—mammalian vulva—uterine cancer	0.00262	0.00865	CbGeAlD
Dipyridamole—PDE5A—epithelium—uterine cancer	0.0025	0.00827	CbGeAlD
Dipyridamole—PDE5A—uterine cervix—uterine cancer	0.00248	0.0082	CbGeAlD
Dipyridamole—PDE8A—female gonad—uterine cancer	0.00248	0.00819	CbGeAlD
Dipyridamole—PDE8A—vagina—uterine cancer	0.00247	0.00814	CbGeAlD
Dipyridamole—PDE5A—smooth muscle tissue—uterine cancer	0.00241	0.00796	CbGeAlD
Dipyridamole—PDE1A—female gonad—uterine cancer	0.0024	0.00793	CbGeAlD
Dipyridamole—PDE3A—smooth muscle tissue—uterine cancer	0.00235	0.00775	CbGeAlD
Dipyridamole—PDE5A—renal system—uterine cancer	0.00232	0.00767	CbGeAlD
Dipyridamole—ABCC5—uterine cervix—uterine cancer	0.00227	0.0075	CbGeAlD
Dipyridamole—ADA—female reproductive system—uterine cancer	0.00225	0.00741	CbGeAlD
Dipyridamole—PDE7B—lymph node—uterine cancer	0.00223	0.00736	CbGeAlD
Dipyridamole—ABCC5—decidua—uterine cancer	0.00216	0.00714	CbGeAlD
Dipyridamole—SLC29A1—uterine cervix—uterine cancer	0.00208	0.00688	CbGeAlD
Dipyridamole—ADA—vagina—uterine cancer	0.00203	0.0067	CbGeAlD
Dipyridamole—PDE4A—female gonad—uterine cancer	0.00199	0.00657	CbGeAlD
Dipyridamole—SLC29A1—decidua—uterine cancer	0.00199	0.00656	CbGeAlD
Dipyridamole—SLC29A1—renal system—uterine cancer	0.00195	0.00644	CbGeAlD
Dipyridamole—SLC29A1—endometrium—uterine cancer	0.00189	0.00622	CbGeAlD
Dipyridamole—PDE5A—female reproductive system—uterine cancer	0.00186	0.00614	CbGeAlD
Dipyridamole—PDE2A—lymph node—uterine cancer	0.00186	0.00614	CbGeAlD
Dipyridamole—PDE10A—lymph node—uterine cancer	0.00186	0.00614	CbGeAlD
Dipyridamole—PDE1B—lymph node—uterine cancer	0.00184	0.00608	CbGeAlD
Dipyridamole—SLC29A1—mammalian vulva—uterine cancer	0.00182	0.00602	CbGeAlD
Dipyridamole—PDE3A—female reproductive system—uterine cancer	0.00181	0.00597	CbGeAlD
Dipyridamole—PDE8B—lymph node—uterine cancer	0.00177	0.00586	CbGeAlD
Dipyridamole—SLC29A1—uterus—uterine cancer	0.00174	0.00574	CbGeAlD
Dipyridamole—PDE3B—lymph node—uterine cancer	0.00173	0.00572	CbGeAlD
Dipyridamole—PDE5A—female gonad—uterine cancer	0.00169	0.00559	CbGeAlD
Dipyridamole—PDE5A—vagina—uterine cancer	0.00168	0.00555	CbGeAlD
Dipyridamole—PDE3A—female gonad—uterine cancer	0.00165	0.00544	CbGeAlD
Dipyridamole—PDE8A—lymph node—uterine cancer	0.0016	0.00527	CbGeAlD
Dipyridamole—SLC29A1—female reproductive system—uterine cancer	0.00156	0.00516	CbGeAlD
Dipyridamole—ABCC5—female gonad—uterine cancer	0.00155	0.00511	CbGeAlD
Dipyridamole—PDE1A—lymph node—uterine cancer	0.00154	0.0051	CbGeAlD
Dipyridamole—ABCC5—vagina—uterine cancer	0.00154	0.00508	CbGeAlD
Dipyridamole—ABCC4—renal system—uterine cancer	0.00147	0.00486	CbGeAlD
Dipyridamole—SLC29A1—female gonad—uterine cancer	0.00142	0.00469	CbGeAlD
Dipyridamole—SLC29A1—vagina—uterine cancer	0.00141	0.00466	CbGeAlD
Dipyridamole—ADA—lymph node—uterine cancer	0.00131	0.00433	CbGeAlD
Dipyridamole—ABCC4—uterus—uterine cancer	0.00131	0.00433	CbGeAlD
Dipyridamole—PDE4A—lymph node—uterine cancer	0.00128	0.00422	CbGeAlD
Dipyridamole—ABCC4—female reproductive system—uterine cancer	0.00118	0.00389	CbGeAlD
Dipyridamole—PDE5A—lymph node—uterine cancer	0.00109	0.00359	CbGeAlD
Dipyridamole—ABCC4—female gonad—uterine cancer	0.00107	0.00354	CbGeAlD
Dipyridamole—PDE3A—lymph node—uterine cancer	0.00106	0.00349	CbGeAlD
Dipyridamole—ABCC5—lymph node—uterine cancer	0.000995	0.00329	CbGeAlD
Dipyridamole—SLC29A1—lymph node—uterine cancer	0.000914	0.00302	CbGeAlD
Dipyridamole—ABCB1—myometrium—uterine cancer	0.000704	0.00232	CbGeAlD
Dipyridamole—ABCC4—lymph node—uterine cancer	0.00069	0.00228	CbGeAlD
Dipyridamole—Pruritus—Progesterone—uterine cancer	0.000673	0.00161	CcSEcCtD
Dipyridamole—Oedema—Dactinomycin—uterine cancer	0.000673	0.00161	CcSEcCtD
Dipyridamole—Hypertonia—Epirubicin—uterine cancer	0.00067	0.00161	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dactinomycin—uterine cancer	0.000659	0.00158	CcSEcCtD
Dipyridamole—Diarrhoea—Progesterone—uterine cancer	0.000651	0.00156	CcSEcCtD
Dipyridamole—Flushing—Etoposide—uterine cancer	0.000636	0.00152	CcSEcCtD
Dipyridamole—Cardiac disorder—Etoposide—uterine cancer	0.000636	0.00152	CcSEcCtD
Dipyridamole—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000635	0.00152	CcSEcCtD
Dipyridamole—Hepatic function abnormal—Epirubicin—uterine cancer	0.000635	0.00152	CcSEcCtD
Dipyridamole—Pulmonary oedema—Doxorubicin—uterine cancer	0.00063	0.00151	CcSEcCtD
Dipyridamole—Dizziness—Progesterone—uterine cancer	0.000629	0.00151	CcSEcCtD
Dipyridamole—Angiopathy—Etoposide—uterine cancer	0.000622	0.00149	CcSEcCtD
Dipyridamole—Hypertonia—Doxorubicin—uterine cancer	0.00062	0.00149	CcSEcCtD
Dipyridamole—Immune system disorder—Etoposide—uterine cancer	0.000619	0.00148	CcSEcCtD
Dipyridamole—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.00148	CcSEcCtD
Dipyridamole—Mediastinal disorder—Etoposide—uterine cancer	0.000618	0.00148	CcSEcCtD
Dipyridamole—Eye pain—Epirubicin—uterine cancer	0.000615	0.00147	CcSEcCtD
Dipyridamole—Chills—Etoposide—uterine cancer	0.000615	0.00147	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000613	0.00147	CcSEcCtD
Dipyridamole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00061	0.00146	CcSEcCtD
Dipyridamole—Alopecia—Etoposide—uterine cancer	0.000605	0.00145	CcSEcCtD
Dipyridamole—Vomiting—Progesterone—uterine cancer	0.000605	0.00145	CcSEcCtD
Dipyridamole—Rash—Progesterone—uterine cancer	0.0006	0.00144	CcSEcCtD
Dipyridamole—Dermatitis—Progesterone—uterine cancer	0.000599	0.00144	CcSEcCtD
Dipyridamole—Headache—Progesterone—uterine cancer	0.000596	0.00143	CcSEcCtD
Dipyridamole—Hot flush—Epirubicin—uterine cancer	0.000594	0.00142	CcSEcCtD
Dipyridamole—Increased appetite—Epirubicin—uterine cancer	0.000591	0.00142	CcSEcCtD
Dipyridamole—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00059	0.00141	CcSEcCtD
Dipyridamole—Menopausal symptoms—Epirubicin—uterine cancer	0.000588	0.00141	CcSEcCtD
Dipyridamole—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000588	0.00141	CcSEcCtD
Dipyridamole—Dysgeusia—Etoposide—uterine cancer	0.000584	0.0014	CcSEcCtD
Dipyridamole—Fatigue—Dactinomycin—uterine cancer	0.00058	0.00139	CcSEcCtD
Dipyridamole—Back pain—Etoposide—uterine cancer	0.000577	0.00138	CcSEcCtD
Dipyridamole—Pain—Dactinomycin—uterine cancer	0.000575	0.00138	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000574	0.00138	CcSEcCtD
Dipyridamole—Muscle spasms—Etoposide—uterine cancer	0.000573	0.00137	CcSEcCtD
Dipyridamole—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00057	0.00137	CcSEcCtD
Dipyridamole—Eye pain—Doxorubicin—uterine cancer	0.000569	0.00136	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Epirubicin—uterine cancer	0.000567	0.00136	CcSEcCtD
Dipyridamole—Nausea—Progesterone—uterine cancer	0.000565	0.00136	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000555	0.00133	CcSEcCtD
Dipyridamole—Feeling abnormal—Dactinomycin—uterine cancer	0.000554	0.00133	CcSEcCtD
Dipyridamole—Ill-defined disorder—Etoposide—uterine cancer	0.000553	0.00133	CcSEcCtD
Dipyridamole—ABCB1—epithelium—uterine cancer	0.000553	0.00182	CbGeAlD
Dipyridamole—Anaemia—Etoposide—uterine cancer	0.000551	0.00132	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00055	0.00132	CcSEcCtD
Dipyridamole—Hot flush—Doxorubicin—uterine cancer	0.000549	0.00132	CcSEcCtD
Dipyridamole—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000548	0.00131	CcSEcCtD
Dipyridamole—ABCB1—uterine cervix—uterine cancer	0.000548	0.00181	CbGeAlD
Dipyridamole—Increased appetite—Doxorubicin—uterine cancer	0.000547	0.00131	CcSEcCtD
Dipyridamole—Migraine—Epirubicin—uterine cancer	0.000546	0.00131	CcSEcCtD
Dipyridamole—Menopausal symptoms—Doxorubicin—uterine cancer	0.000544	0.00131	CcSEcCtD
Dipyridamole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000544	0.0013	CcSEcCtD
Dipyridamole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.0013	CcSEcCtD
Dipyridamole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00054	0.0013	CcSEcCtD
Dipyridamole—Malaise—Etoposide—uterine cancer	0.000538	0.00129	CcSEcCtD
Dipyridamole—Vertigo—Etoposide—uterine cancer	0.000536	0.00128	CcSEcCtD
Dipyridamole—Abdominal pain—Dactinomycin—uterine cancer	0.000532	0.00127	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000531	0.00127	CcSEcCtD
Dipyridamole—Cardiac arrest—Epirubicin—uterine cancer	0.000528	0.00127	CcSEcCtD
Dipyridamole—Loss of consciousness—Etoposide—uterine cancer	0.000524	0.00126	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000524	0.00126	CcSEcCtD
Dipyridamole—ABCB1—decidua—uterine cancer	0.000522	0.00172	CbGeAlD
Dipyridamole—Cough—Etoposide—uterine cancer	0.00052	0.00125	CcSEcCtD
Dipyridamole—Convulsion—Etoposide—uterine cancer	0.000517	0.00124	CcSEcCtD
Dipyridamole—Hypertension—Etoposide—uterine cancer	0.000515	0.00123	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000514	0.00123	CcSEcCtD
Dipyridamole—ABCB1—renal system—uterine cancer	0.000513	0.00169	CbGeAlD
Dipyridamole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000512	0.00123	CcSEcCtD
Dipyridamole—Chest pain—Etoposide—uterine cancer	0.000508	0.00122	CcSEcCtD
Dipyridamole—Abdominal pain upper—Epirubicin—uterine cancer	0.000507	0.00122	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Epirubicin—uterine cancer	0.000507	0.00122	CcSEcCtD
Dipyridamole—Migraine—Doxorubicin—uterine cancer	0.000506	0.00121	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000504	0.00121	CcSEcCtD
Dipyridamole—Discomfort—Etoposide—uterine cancer	0.000502	0.0012	CcSEcCtD
Dipyridamole—ABCB1—endometrium—uterine cancer	0.000496	0.00164	CbGeAlD
Dipyridamole—Hypersensitivity—Dactinomycin—uterine cancer	0.000496	0.00119	CcSEcCtD
Dipyridamole—Cardiac arrest—Doxorubicin—uterine cancer	0.000488	0.00117	CcSEcCtD
Dipyridamole—Anaphylactic shock—Etoposide—uterine cancer	0.000487	0.00117	CcSEcCtD
Dipyridamole—Asthenia—Dactinomycin—uterine cancer	0.000483	0.00116	CcSEcCtD
Dipyridamole—Dysphagia—Epirubicin—uterine cancer	0.00048	0.00115	CcSEcCtD
Dipyridamole—ABCB1—mammalian vulva—uterine cancer	0.000479	0.00158	CbGeAlD
Dipyridamole—Thrombocytopenia—Etoposide—uterine cancer	0.000477	0.00114	CcSEcCtD
Dipyridamole—Tachycardia—Etoposide—uterine cancer	0.000475	0.00114	CcSEcCtD
Dipyridamole—Skin disorder—Etoposide—uterine cancer	0.000473	0.00113	CcSEcCtD
Dipyridamole—Hyperhidrosis—Etoposide—uterine cancer	0.000471	0.00113	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000469	0.00112	CcSEcCtD
Dipyridamole—Abdominal pain upper—Doxorubicin—uterine cancer	0.000469	0.00112	CcSEcCtD
Dipyridamole—Angina pectoris—Epirubicin—uterine cancer	0.000467	0.00112	CcSEcCtD
Dipyridamole—Diarrhoea—Dactinomycin—uterine cancer	0.00046	0.0011	CcSEcCtD
Dipyridamole—ABCB1—uterus—uterine cancer	0.000457	0.00151	CbGeAlD
Dipyridamole—Hypotension—Etoposide—uterine cancer	0.000455	0.00109	CcSEcCtD
Dipyridamole—Dysphagia—Doxorubicin—uterine cancer	0.000444	0.00106	CcSEcCtD
Dipyridamole—Paraesthesia—Etoposide—uterine cancer	0.000437	0.00105	CcSEcCtD
Dipyridamole—Dyspnoea—Etoposide—uterine cancer	0.000434	0.00104	CcSEcCtD
Dipyridamole—Somnolence—Etoposide—uterine cancer	0.000433	0.00104	CcSEcCtD
Dipyridamole—Angina pectoris—Doxorubicin—uterine cancer	0.000432	0.00104	CcSEcCtD
Dipyridamole—Vomiting—Dactinomycin—uterine cancer	0.000428	0.00103	CcSEcCtD
Dipyridamole—Rash—Dactinomycin—uterine cancer	0.000424	0.00102	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Etoposide—uterine cancer	0.00042	0.00101	CcSEcCtD
Dipyridamole—Fatigue—Etoposide—uterine cancer	0.00042	0.00101	CcSEcCtD
Dipyridamole—Pain—Etoposide—uterine cancer	0.000416	0.000998	CcSEcCtD
Dipyridamole—ABCB1—female reproductive system—uterine cancer	0.000411	0.00136	CbGeAlD
Dipyridamole—Feeling abnormal—Etoposide—uterine cancer	0.000401	0.000962	CcSEcCtD
Dipyridamole—Nausea—Dactinomycin—uterine cancer	0.0004	0.000958	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Etoposide—uterine cancer	0.000398	0.000954	CcSEcCtD
Dipyridamole—Bradycardia—Epirubicin—uterine cancer	0.000391	0.000937	CcSEcCtD
Dipyridamole—Urticaria—Etoposide—uterine cancer	0.000387	0.000927	CcSEcCtD
Dipyridamole—Haemoglobin—Epirubicin—uterine cancer	0.000386	0.000926	CcSEcCtD
Dipyridamole—Rhinitis—Epirubicin—uterine cancer	0.000385	0.000923	CcSEcCtD
Dipyridamole—Abdominal pain—Etoposide—uterine cancer	0.000385	0.000923	CcSEcCtD
Dipyridamole—Haemorrhage—Epirubicin—uterine cancer	0.000384	0.000921	CcSEcCtD
Dipyridamole—Hepatitis—Epirubicin—uterine cancer	0.000384	0.000921	CcSEcCtD
Dipyridamole—Hypoaesthesia—Epirubicin—uterine cancer	0.000382	0.000916	CcSEcCtD
Dipyridamole—Pharyngitis—Epirubicin—uterine cancer	0.000381	0.000914	CcSEcCtD
Dipyridamole—ABCB1—female gonad—uterine cancer	0.000374	0.00123	CbGeAlD
Dipyridamole—ABCB1—vagina—uterine cancer	0.000371	0.00123	CbGeAlD
Dipyridamole—Bradycardia—Doxorubicin—uterine cancer	0.000362	0.000867	CcSEcCtD
Dipyridamole—Hypersensitivity—Etoposide—uterine cancer	0.000359	0.00086	CcSEcCtD
Dipyridamole—Tinnitus—Epirubicin—uterine cancer	0.000358	0.000859	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—uterine cancer	0.000357	0.000856	CcSEcCtD
Dipyridamole—Cardiac disorder—Epirubicin—uterine cancer	0.000356	0.000855	CcSEcCtD
Dipyridamole—Flushing—Epirubicin—uterine cancer	0.000356	0.000855	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—uterine cancer	0.000356	0.000854	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—uterine cancer	0.000355	0.000852	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—uterine cancer	0.000355	0.000852	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—uterine cancer	0.000354	0.000848	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—uterine cancer	0.000353	0.000846	CcSEcCtD
Dipyridamole—Asthenia—Etoposide—uterine cancer	0.000349	0.000837	CcSEcCtD
Dipyridamole—Angiopathy—Epirubicin—uterine cancer	0.000348	0.000836	CcSEcCtD
Dipyridamole—Immune system disorder—Epirubicin—uterine cancer	0.000347	0.000832	CcSEcCtD
Dipyridamole—Mediastinal disorder—Epirubicin—uterine cancer	0.000346	0.00083	CcSEcCtD
Dipyridamole—Chills—Epirubicin—uterine cancer	0.000345	0.000826	CcSEcCtD
Dipyridamole—Pruritus—Etoposide—uterine cancer	0.000344	0.000826	CcSEcCtD
Dipyridamole—Arrhythmia—Epirubicin—uterine cancer	0.000343	0.000823	CcSEcCtD
Dipyridamole—Alopecia—Epirubicin—uterine cancer	0.000339	0.000814	CcSEcCtD
Dipyridamole—Diarrhoea—Etoposide—uterine cancer	0.000333	0.000799	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—uterine cancer	0.000331	0.000794	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—uterine cancer	0.00033	0.000791	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—uterine cancer	0.00033	0.000791	CcSEcCtD
Dipyridamole—Flatulence—Epirubicin—uterine cancer	0.000329	0.00079	CcSEcCtD
Dipyridamole—Tension—Epirubicin—uterine cancer	0.000328	0.000787	CcSEcCtD
Dipyridamole—Dysgeusia—Epirubicin—uterine cancer	0.000327	0.000785	CcSEcCtD
Dipyridamole—Nervousness—Epirubicin—uterine cancer	0.000325	0.000779	CcSEcCtD
Dipyridamole—Back pain—Epirubicin—uterine cancer	0.000323	0.000775	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—uterine cancer	0.000322	0.000773	CcSEcCtD
Dipyridamole—Dizziness—Etoposide—uterine cancer	0.000322	0.000772	CcSEcCtD
Dipyridamole—Muscle spasms—Epirubicin—uterine cancer	0.000321	0.000771	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—uterine cancer	0.000321	0.00077	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—uterine cancer	0.00032	0.000768	CcSEcCtD
Dipyridamole—Chills—Doxorubicin—uterine cancer	0.000319	0.000765	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—uterine cancer	0.000317	0.000761	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—uterine cancer	0.000314	0.000753	CcSEcCtD
Dipyridamole—Ill-defined disorder—Epirubicin—uterine cancer	0.00031	0.000744	CcSEcCtD
Dipyridamole—Vomiting—Etoposide—uterine cancer	0.00031	0.000742	CcSEcCtD
Dipyridamole—Anaemia—Epirubicin—uterine cancer	0.000309	0.000741	CcSEcCtD
Dipyridamole—Rash—Etoposide—uterine cancer	0.000307	0.000736	CcSEcCtD
Dipyridamole—Dermatitis—Etoposide—uterine cancer	0.000307	0.000735	CcSEcCtD
Dipyridamole—Headache—Etoposide—uterine cancer	0.000305	0.000731	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—uterine cancer	0.000305	0.000731	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—uterine cancer	0.000304	0.000728	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—uterine cancer	0.000303	0.000726	CcSEcCtD
Dipyridamole—Malaise—Epirubicin—uterine cancer	0.000302	0.000723	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—uterine cancer	0.0003	0.00072	CcSEcCtD
Dipyridamole—Vertigo—Epirubicin—uterine cancer	0.0003	0.00072	CcSEcCtD
Dipyridamole—Syncope—Epirubicin—uterine cancer	0.0003	0.000719	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—uterine cancer	0.000299	0.000717	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—uterine cancer	0.000297	0.000713	CcSEcCtD
Dipyridamole—Palpitations—Epirubicin—uterine cancer	0.000295	0.000708	CcSEcCtD
Dipyridamole—Loss of consciousness—Epirubicin—uterine cancer	0.000294	0.000705	CcSEcCtD
Dipyridamole—Cough—Epirubicin—uterine cancer	0.000292	0.0007	CcSEcCtD
Dipyridamole—Convulsion—Epirubicin—uterine cancer	0.00029	0.000695	CcSEcCtD
Dipyridamole—Nausea—Etoposide—uterine cancer	0.000289	0.000693	CcSEcCtD
Dipyridamole—Hypertension—Epirubicin—uterine cancer	0.000289	0.000692	CcSEcCtD
Dipyridamole—Ill-defined disorder—Doxorubicin—uterine cancer	0.000287	0.000688	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—uterine cancer	0.000286	0.000686	CcSEcCtD
Dipyridamole—Chest pain—Epirubicin—uterine cancer	0.000285	0.000682	CcSEcCtD
Dipyridamole—Myalgia—Epirubicin—uterine cancer	0.000285	0.000682	CcSEcCtD
Dipyridamole—Arthralgia—Epirubicin—uterine cancer	0.000285	0.000682	CcSEcCtD
Dipyridamole—Anxiety—Epirubicin—uterine cancer	0.000284	0.00068	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000283	0.000678	CcSEcCtD
Dipyridamole—Discomfort—Epirubicin—uterine cancer	0.000281	0.000674	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—uterine cancer	0.000279	0.000669	CcSEcCtD
Dipyridamole—Dry mouth—Epirubicin—uterine cancer	0.000278	0.000667	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—uterine cancer	0.000278	0.000666	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—uterine cancer	0.000277	0.000665	CcSEcCtD
Dipyridamole—Palpitations—Doxorubicin—uterine cancer	0.000273	0.000655	CcSEcCtD
Dipyridamole—Anaphylactic shock—Epirubicin—uterine cancer	0.000273	0.000654	CcSEcCtD
Dipyridamole—Oedema—Epirubicin—uterine cancer	0.000273	0.000654	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—uterine cancer	0.000272	0.000652	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—uterine cancer	0.00027	0.000647	CcSEcCtD
Dipyridamole—Shock—Epirubicin—uterine cancer	0.000268	0.000644	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—uterine cancer	0.000268	0.000643	CcSEcCtD
Dipyridamole—Nervous system disorder—Epirubicin—uterine cancer	0.000268	0.000642	CcSEcCtD
Dipyridamole—Thrombocytopenia—Epirubicin—uterine cancer	0.000267	0.000641	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—uterine cancer	0.000267	0.00064	CcSEcCtD
Dipyridamole—Tachycardia—Epirubicin—uterine cancer	0.000266	0.000639	CcSEcCtD
Dipyridamole—Skin disorder—Epirubicin—uterine cancer	0.000265	0.000635	CcSEcCtD
Dipyridamole—Hyperhidrosis—Epirubicin—uterine cancer	0.000264	0.000632	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—uterine cancer	0.000263	0.000631	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—uterine cancer	0.000263	0.000631	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—uterine cancer	0.000263	0.000631	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—uterine cancer	0.000262	0.000629	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000262	0.000627	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—uterine cancer	0.00026	0.000624	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—uterine cancer	0.000258	0.000618	CcSEcCtD
Dipyridamole—Hypotension—Epirubicin—uterine cancer	0.000255	0.000611	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—uterine cancer	0.000252	0.000605	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—uterine cancer	0.000252	0.000605	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000249	0.000596	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—uterine cancer	0.000248	0.000596	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—uterine cancer	0.000248	0.000594	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—uterine cancer	0.000247	0.000593	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—uterine cancer	0.000246	0.000591	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—uterine cancer	0.000245	0.000588	CcSEcCtD
Dipyridamole—Paraesthesia—Epirubicin—uterine cancer	0.000245	0.000587	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—uterine cancer	0.000244	0.000585	CcSEcCtD
Dipyridamole—Dyspnoea—Epirubicin—uterine cancer	0.000243	0.000583	CcSEcCtD
Dipyridamole—Somnolence—Epirubicin—uterine cancer	0.000243	0.000582	CcSEcCtD
Dipyridamole—Dyspepsia—Epirubicin—uterine cancer	0.00024	0.000576	CcSEcCtD
Dipyridamole—ABCB1—lymph node—uterine cancer	0.00024	0.000793	CbGeAlD
Dipyridamole—Hypotension—Doxorubicin—uterine cancer	0.000236	0.000566	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000236	0.000565	CcSEcCtD
Dipyridamole—Fatigue—Epirubicin—uterine cancer	0.000235	0.000564	CcSEcCtD
Dipyridamole—Pain—Epirubicin—uterine cancer	0.000233	0.000559	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00023	0.000552	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—uterine cancer	0.000227	0.000544	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—uterine cancer	0.000225	0.00054	CcSEcCtD
Dipyridamole—Feeling abnormal—Epirubicin—uterine cancer	0.000225	0.000539	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—uterine cancer	0.000224	0.000538	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Epirubicin—uterine cancer	0.000223	0.000535	CcSEcCtD
Dipyridamole—Dyspepsia—Doxorubicin—uterine cancer	0.000222	0.000533	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000218	0.000523	CcSEcCtD
Dipyridamole—Fatigue—Doxorubicin—uterine cancer	0.000218	0.000522	CcSEcCtD
Dipyridamole—Urticaria—Epirubicin—uterine cancer	0.000217	0.00052	CcSEcCtD
Dipyridamole—Pain—Doxorubicin—uterine cancer	0.000216	0.000518	CcSEcCtD
Dipyridamole—Abdominal pain—Epirubicin—uterine cancer	0.000216	0.000517	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—uterine cancer	0.000208	0.000499	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000206	0.000495	CcSEcCtD
Dipyridamole—Hypersensitivity—Epirubicin—uterine cancer	0.000201	0.000482	CcSEcCtD
Dipyridamole—Urticaria—Doxorubicin—uterine cancer	0.000201	0.000481	CcSEcCtD
Dipyridamole—Abdominal pain—Doxorubicin—uterine cancer	0.0002	0.000479	CcSEcCtD
Dipyridamole—Asthenia—Epirubicin—uterine cancer	0.000196	0.000469	CcSEcCtD
Dipyridamole—Pruritus—Epirubicin—uterine cancer	0.000193	0.000463	CcSEcCtD
Dipyridamole—Diarrhoea—Epirubicin—uterine cancer	0.000187	0.000448	CcSEcCtD
Dipyridamole—Hypersensitivity—Doxorubicin—uterine cancer	0.000186	0.000446	CcSEcCtD
Dipyridamole—Asthenia—Doxorubicin—uterine cancer	0.000181	0.000434	CcSEcCtD
Dipyridamole—Dizziness—Epirubicin—uterine cancer	0.00018	0.000433	CcSEcCtD
Dipyridamole—Pruritus—Doxorubicin—uterine cancer	0.000179	0.000428	CcSEcCtD
Dipyridamole—Vomiting—Epirubicin—uterine cancer	0.000173	0.000416	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—uterine cancer	0.000173	0.000414	CcSEcCtD
Dipyridamole—Rash—Epirubicin—uterine cancer	0.000172	0.000413	CcSEcCtD
Dipyridamole—Dermatitis—Epirubicin—uterine cancer	0.000172	0.000412	CcSEcCtD
Dipyridamole—Headache—Epirubicin—uterine cancer	0.000171	0.00041	CcSEcCtD
Dipyridamole—Dizziness—Doxorubicin—uterine cancer	0.000167	0.0004	CcSEcCtD
Dipyridamole—Nausea—Epirubicin—uterine cancer	0.000162	0.000389	CcSEcCtD
Dipyridamole—Vomiting—Doxorubicin—uterine cancer	0.000161	0.000385	CcSEcCtD
Dipyridamole—Rash—Doxorubicin—uterine cancer	0.000159	0.000382	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—uterine cancer	0.000159	0.000381	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—uterine cancer	0.000158	0.000379	CcSEcCtD
Dipyridamole—Nausea—Doxorubicin—uterine cancer	0.00015	0.00036	CcSEcCtD
Dipyridamole—PDE8A—Signaling Pathways—PIK3CA—uterine cancer	4.19e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—PIK3CA—uterine cancer	4.19e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCL8—uterine cancer	4.18e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EP300—uterine cancer	4.18e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—PIK3CA—uterine cancer	4.16e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FGFR2—uterine cancer	4.15e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—AKT1—uterine cancer	4.13e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ESR1—uterine cancer	4.13e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—uterine cancer	4.12e-05	0.000152	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.09e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—PIK3CA—uterine cancer	4.08e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CDKN1B—uterine cancer	4.08e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NRAS—uterine cancer	4.07e-05	0.00015	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—ERBB2—uterine cancer	4.07e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—ERBB2—uterine cancer	4.07e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—AKT1—uterine cancer	4.06e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—uterine cancer	4.06e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—KRAS—uterine cancer	4.06e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—uterine cancer	4.05e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—uterine cancer	4.05e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ERBB2—uterine cancer	4.03e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—AKT1—uterine cancer	4.02e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—AKT1—uterine cancer	4.02e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NRAS—uterine cancer	4.01e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—NRAS—uterine cancer	4.01e-05	0.000148	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTEN—uterine cancer	4e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCL2—uterine cancer	3.99e-05	0.000147	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—uterine cancer	3.96e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—uterine cancer	3.95e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NRAS—uterine cancer	3.91e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—NRAS—uterine cancer	3.9e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ESR1—uterine cancer	3.88e-05	0.000143	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.88e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—HRAS—uterine cancer	3.87e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—HRAS—uterine cancer	3.87e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CTNNB1—uterine cancer	3.85e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HRAS—uterine cancer	3.85e-05	0.000142	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—KRAS—uterine cancer	3.81e-05	0.000141	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—EP300—uterine cancer	3.81e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—AKT1—uterine cancer	3.78e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—KRAS—uterine cancer	3.78e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—KRAS—uterine cancer	3.78e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—HRAS—uterine cancer	3.77e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CDKN1B—uterine cancer	3.77e-05	0.000139	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CDKN1B—uterine cancer	3.77e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PTEN—uterine cancer	3.76e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—AKT1—uterine cancer	3.75e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL2—uterine cancer	3.73e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—PIK3CA—uterine cancer	3.73e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CDKN1B—uterine cancer	3.73e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—PIK3CA—uterine cancer	3.73e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ERBB2—uterine cancer	3.72e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—uterine cancer	3.72e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—uterine cancer	3.7e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—KRAS—uterine cancer	3.69e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—NRAS—uterine cancer	3.67e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL2—uterine cancer	3.63e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—uterine cancer	3.61e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EP300—uterine cancer	3.58e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CTNNB1—uterine cancer	3.56e-05	0.000132	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CTNNB1—uterine cancer	3.56e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ESR1—uterine cancer	3.55e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CTNNB1—uterine cancer	3.52e-05	0.00013	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—PIK3CA—uterine cancer	3.5e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KRAS—uterine cancer	3.5e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—PIK3CA—uterine cancer	3.49e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PIK3CA—uterine cancer	3.47e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PIK3CA—uterine cancer	3.47e-05	0.000128	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTEN—uterine cancer	3.47e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTEN—uterine cancer	3.47e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KRAS—uterine cancer	3.45e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HRAS—uterine cancer	3.45e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—KRAS—uterine cancer	3.45e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CDKN1B—uterine cancer	3.44e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PTEN—uterine cancer	3.43e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—uterine cancer	3.42e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—uterine cancer	3.42e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL2—uterine cancer	3.42e-05	0.000126	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POLD1—uterine cancer	3.4e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—uterine cancer	3.4e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—PIK3CA—uterine cancer	3.4e-05	0.000126	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—uterine cancer	3.39e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PIK3CA—uterine cancer	3.39e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KRAS—uterine cancer	3.36e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—KRAS—uterine cancer	3.36e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—uterine cancer	3.36e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—uterine cancer	3.36e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—NRAS—uterine cancer	3.35e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NRAS—uterine cancer	3.35e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—uterine cancer	3.33e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB2—uterine cancer	3.33e-05	0.000123	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EP300—uterine cancer	3.31e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EP300—uterine cancer	3.31e-05	0.000122	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.3e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EP300—uterine cancer	3.28e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CTNNB1—uterine cancer	3.25e-05	0.00012	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—HRAS—uterine cancer	3.24e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PIK3CA—uterine cancer	3.22e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HRAS—uterine cancer	3.21e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HRAS—uterine cancer	3.21e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—PIK3CA—uterine cancer	3.19e-05	0.000118	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKR1C1—uterine cancer	3.18e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PIK3CA—uterine cancer	3.17e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTEN—uterine cancer	3.17e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PIK3CA—uterine cancer	3.17e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—KRAS—uterine cancer	3.16e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL8—uterine cancer	3.15e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HRAS—uterine cancer	3.13e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL2—uterine cancer	3.12e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB2—uterine cancer	3.11e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—uterine cancer	3.11e-05	0.000115	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NRAS—uterine cancer	3.09e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NRAS—uterine cancer	3.09e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PIK3CA—uterine cancer	3.09e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PIK3CA—uterine cancer	3.08e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CDKN1B—uterine cancer	3.08e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—uterine cancer	3.07e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NRAS—uterine cancer	3.06e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—uterine cancer	3.05e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—uterine cancer	3.05e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB2—uterine cancer	3.03e-05	0.000112	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.03e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EP300—uterine cancer	3.02e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—uterine cancer	2.99e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—uterine cancer	2.97e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—uterine cancer	2.95e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—uterine cancer	2.93e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—uterine cancer	2.93e-05	0.000108	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.93e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PIK3CA—uterine cancer	2.92e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CTNNB1—uterine cancer	2.91e-05	0.000108	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTEN—uterine cancer	2.9e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—uterine cancer	2.9e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—uterine cancer	2.89e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—uterine cancer	2.88e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDKN1B—uterine cancer	2.88e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—uterine cancer	2.87e-05	0.000106	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—uterine cancer	2.86e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—uterine cancer	2.86e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—uterine cancer	2.85e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—uterine cancer	2.85e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB2—uterine cancer	2.85e-05	0.000105	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—RRM2—uterine cancer	2.84e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTEN—uterine cancer	2.84e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—uterine cancer	2.83e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—uterine cancer	2.83e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NRAS—uterine cancer	2.83e-05	0.000105	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—uterine cancer	2.82e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDKN1B—uterine cancer	2.8e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—uterine cancer	2.77e-05	0.000103	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—EP300—uterine cancer	2.77e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—uterine cancer	2.77e-05	0.000102	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DCN—uterine cancer	2.75e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CTNNB1—uterine cancer	2.72e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EP300—uterine cancer	2.7e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—uterine cancer	2.7e-05	9.98e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—uterine cancer	2.68e-05	9.92e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—uterine cancer	2.66e-05	9.84e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—uterine cancer	2.66e-05	9.84e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTEN—uterine cancer	2.65e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—uterine cancer	2.65e-05	9.8e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CTNNB1—uterine cancer	2.65e-05	9.8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—uterine cancer	2.65e-05	9.79e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—uterine cancer	2.64e-05	9.75e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDKN1B—uterine cancer	2.64e-05	9.75e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—uterine cancer	2.63e-05	9.71e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—uterine cancer	2.61e-05	9.64e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB2—uterine cancer	2.6e-05	9.63e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP11A1—uterine cancer	2.59e-05	9.59e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—uterine cancer	2.59e-05	9.58e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—uterine cancer	2.59e-05	9.57e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTEN—uterine cancer	2.58e-05	9.55e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—uterine cancer	2.56e-05	9.47e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EP300—uterine cancer	2.53e-05	9.36e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NRAS—uterine cancer	2.53e-05	9.35e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—uterine cancer	2.53e-05	9.34e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—uterine cancer	2.52e-05	9.31e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CTNNB1—uterine cancer	2.49e-05	9.21e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.47e-05	9.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—uterine cancer	2.47e-05	9.13e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EP300—uterine cancer	2.46e-05	9.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—uterine cancer	2.45e-05	9.07e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—uterine cancer	2.45e-05	9.06e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKR1C3—uterine cancer	2.45e-05	9.06e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—uterine cancer	2.45e-05	9.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—uterine cancer	2.45e-05	9.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—uterine cancer	2.44e-05	9e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTEN—uterine cancer	2.43e-05	8.98e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—uterine cancer	2.42e-05	8.96e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDKN1B—uterine cancer	2.41e-05	8.92e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—uterine cancer	2.4e-05	8.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—uterine cancer	2.39e-05	8.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—uterine cancer	2.37e-05	8.76e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NRAS—uterine cancer	2.37e-05	8.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—uterine cancer	2.33e-05	8.62e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EP300—uterine cancer	2.32e-05	8.56e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NRAS—uterine cancer	2.3e-05	8.52e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—uterine cancer	2.3e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CTNNB1—uterine cancer	2.28e-05	8.42e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—uterine cancer	2.26e-05	8.37e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—uterine cancer	2.26e-05	8.37e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—uterine cancer	2.24e-05	8.29e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—uterine cancer	2.24e-05	8.27e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTEN—uterine cancer	2.22e-05	8.21e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—uterine cancer	2.19e-05	8.11e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—uterine cancer	2.18e-05	8.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—uterine cancer	2.17e-05	8.01e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NRAS—uterine cancer	2.17e-05	8.01e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—uterine cancer	2.16e-05	8e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EP300—uterine cancer	2.12e-05	7.83e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—uterine cancer	2.07e-05	7.65e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—uterine cancer	2.05e-05	7.57e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—uterine cancer	2.04e-05	7.54e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—uterine cancer	2.01e-05	7.42e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—uterine cancer	2e-05	7.39e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—uterine cancer	2e-05	7.39e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—uterine cancer	2e-05	7.39e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—uterine cancer	1.98e-05	7.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NRAS—uterine cancer	1.98e-05	7.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—uterine cancer	1.98e-05	7.32e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—uterine cancer	1.94e-05	7.15e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP19A1—uterine cancer	1.91e-05	7.06e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—STK11—uterine cancer	1.91e-05	7.06e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—uterine cancer	1.87e-05	6.92e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—uterine cancer	1.86e-05	6.89e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—uterine cancer	1.85e-05	6.84e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—uterine cancer	1.83e-05	6.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—uterine cancer	1.82e-05	6.74e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—uterine cancer	1.81e-05	6.7e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—uterine cancer	1.76e-05	6.52e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—uterine cancer	1.73e-05	6.41e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—uterine cancer	1.71e-05	6.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—uterine cancer	1.71e-05	6.3e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—uterine cancer	1.69e-05	6.23e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—uterine cancer	1.67e-05	6.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—uterine cancer	1.66e-05	6.13e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—uterine cancer	1.63e-05	6.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—uterine cancer	1.58e-05	5.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—uterine cancer	1.57e-05	5.79e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—uterine cancer	1.53e-05	5.66e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—uterine cancer	1.52e-05	5.6e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—uterine cancer	1.49e-05	5.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—uterine cancer	1.45e-05	5.36e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—uterine cancer	1.43e-05	5.3e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—uterine cancer	1.4e-05	5.17e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—uterine cancer	1.28e-05	4.73e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTEN—uterine cancer	7.98e-06	2.95e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—EP300—uterine cancer	7.61e-06	2.81e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—uterine cancer	5.63e-06	2.08e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—uterine cancer	4.6e-06	1.7e-05	CbGpPWpGaD
